Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single ...
FDA Recall #D-0594-2024 — Class II — July 3, 2024
Product Description
Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Compounded drug by Medivant Healthcare, 158 S Kyrene Rd, Chandler, AZ 85226, NDC 81483-0038-0, UPC 3 81483 00380 2
Reason for Recall
Subpotent Drug: reduced efficacy for epinephrine
Recalling Firm
TAILSTORM HEALTH INC — Chandler, AZ
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
12,525 10 mL vials
Distribution
Nationwide in the USA
Code Information
Lot Number: 2311003, Expiration Date: 11/13/2024
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated